- When did Emmaus Life Sciences, Inc. go public?
Emmaus went public on July 18, 2019 following a stock-for-stock merger with MYnd Analytics, Inc. The merger became effective following approval by Emmaus’ and MYnd Analytics’ shareholders, respectively, at special meetings of shareholders held by each company on July 9, 2019.
- What is Emmaus Life Sciences, Inc.'s stock symbol?
Our stock is traded OTC under the symbol EMMA.
- Why did Emmaus Life Sciences chose the stock-for-stock merger as a vehicle for going public?
We believe that the stock-for-stock merger represented a much more efficient and economical way to provide value for the company’s shareholders.
- Who should I contact if I have questions about the merger?
Please contact our information agent:
Broadridge Corporate Issuer Solutions, Inc.
T: 855-600-2571
shareholder@broadridge.com- When was Emmaus Life Sciences, Inc. incorporated?
September 24, 2007
- What is Emmaus Life Sciences, Inc.’s CUSIP number?
Our CUSIP number is 29137T 101
- Where is Emmaus Life Sciences, Inc. located?
21250 Hawthorne Blvd.
Suite 800
Torrance, CA 90503- When is Emmaus Life Sciences, Inc.'s fiscal year end?
December 31st
- Who is Emmaus Life Sciences, Inc.'s transfer agent?
American Stock Transfer & Trust Company
Brooklyn, NY
T: 800-937-5449/718-921-8124
help@astfinancial.com- What should I do if I lose my stock certificate or need to change my address?
Please contact our transfer agent, as listed above.
- Who is Emmaus Life Sciences, Inc.'s outside legal counsel?
Gibson, Dunn & Crutcher LLP
San Francisco, CA- How can I contact the Emmaus Life Sciences, Inc. Board of Directors?
You can contact our Board at:
Emmaus Life Sciences, Inc. Board of Directors
c/o Dale Short, General Counsel
21250 Hawthorne Blvd.
Suite 800
Torrance, CA 90503
